Prg Science & Technology Co., Ltd.

This early-stage trial tests an experimental drug called PRG-N-01 in 25 adults with neurofibromatosis type II (NF2), a genetic condition that causes non-cancerous tumors. The study aims to find the safest and most effective dose, and to see if the drug can shrink tumors and impro…

This study tests a drug called Progerinin in 5 adults with Werner syndrome, a rare genetic condition that causes premature aging and bone loss. The goal is to see if the drug is safe and tolerable over one year. Participants take Progerinin twice daily, and researchers monitor si…